
For much of modern medicine, the male body was treated as the default. In 1977, FDA guidance recommended excluding women of childbearing potential from early phases of drug trials. That policy changed in the early 1990s, and in 1993, the NIH Revitalization Act made the inclusion of women in NIH-funded clinical research a matter of […]
read now